{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:46:55Z","timestamp":1775051215311,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["5047870"],"award-info":[{"award-number":["5047870"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["5047870"],"award-info":[{"award-number":["5047870"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["5047870"],"award-info":[{"award-number":["5047870"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10067-023-06685-7","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T10:01:37Z","timestamp":1688724097000},"page":"2881-2887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating levels of galectin-3 and coronary microvascular perfusion in rheumatoid arthritis patients with suppressed inflammation"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5658-4629","authenticated-orcid":false,"given":"Panagiota","family":"Anyfanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Dimitriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasia","family":"Dara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Angeloudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gavriilaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Nikolaidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areti","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Gkaliagkousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"6685_CR1","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.2147\/JIR.S276986","volume":"14","author":"P Anyfanti","year":"2021","unstructured":"Anyfanti P, Dara A, Angeloudi E et al (2021) Monitoring and managing cardiovascular risk in immune mediated inflammatory diseases. J Inflamm Res 14:6893\u20136906. https:\/\/doi.org\/10.2147\/JIR.S276986","journal-title":"J Inflamm Res"},{"key":"6685_CR2","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/nf05o4","author":"P Anyfanti","year":"2022","unstructured":"Anyfanti P, Gavriilaki E, Dolgyras P et al (2022) Skin microcirculation dynamics are impaired in patients with rheumatoid arthritis and no cardiovascular comorbidities. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/nf05o4","journal-title":"Clin Exp Rheumatol"},{"key":"6685_CR3","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/life12081167","volume":"12","author":"P Anyfanti","year":"2022","unstructured":"Anyfanti P, Angeloudi E, Dara A et al (2022) Nailfold videocapillaroscopy for the evaluation of peripheral microangiopathy in rheumatoid arthritis. Life 12:1167. https:\/\/doi.org\/10.3390\/life12081167","journal-title":"Life"},{"key":"6685_CR4","doi-asserted-by":"publisher","first-page":"e12417","DOI":"10.1111\/micc.12417","volume":"24","author":"P Anyfanti","year":"2017","unstructured":"Anyfanti P, Triantafyllou A, Gkaliagkousi E et al (2017) Retinal vessel morphology in rheumatoid arthritis: association with systemic inflammation, subclinical atherosclerosis, and cardiovascular risk. Microcirculation 24:e12417. https:\/\/doi.org\/10.1111\/micc.12417","journal-title":"Microcirculation"},{"key":"6685_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10067-017-3659-9","volume":"36","author":"P Anyfanti","year":"2017","unstructured":"Anyfanti P, Triantafyllou A, Gkaliagkousi E et al (2017) Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors. Clin Rheumatol 36:1229\u20131236. https:\/\/doi.org\/10.1007\/s10067-017-3659-9","journal-title":"Clin Rheumatol"},{"key":"6685_CR6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1002\/art.23798","volume":"58","author":"JM Davis","year":"2008","unstructured":"Davis JM, Roger VL, Crowson CS et al (2008) The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 58:2603\u20132611. https:\/\/doi.org\/10.1002\/art.23798","journal-title":"Arthritis Rheum"},{"key":"6685_CR7","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.3390\/ijms21239232","volume":"21","author":"V Blanda","year":"2020","unstructured":"Blanda V, Bracale UM, Di Taranto MD, Fortunato G (2020) Galectin-3 in cardiovascular diseases. Int J Mol Sci 21:9232. https:\/\/doi.org\/10.3390\/ijms21239232","journal-title":"Int J Mol Sci"},{"key":"6685_CR8","doi-asserted-by":"publisher","unstructured":"Li M, Guo K, Huang X, et al (2022) Association between serum galectin-3 levels and coronary stenosis severity in patients with coronary artery disease. Front Cardiovasc Med 9. https:\/\/doi.org\/10.3389\/fcvm.2022.818162","DOI":"10.3389\/fcvm.2022.818162"},{"key":"6685_CR9","doi-asserted-by":"publisher","unstructured":"Mendez-Huergo SP, Hockl PF, Stupirski JC, et al (2019) Clinical relevance of galectin-1 and galectin-3 in rheumatoid arthritis patients: differential regulation and correlation with disease activity. Front Immunol 9. https:\/\/doi.org\/10.3389\/fimmu.2018.03057","DOI":"10.3389\/fimmu.2018.03057"},{"key":"6685_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13075-017-1282-4","volume":"19","author":"SF Issa","year":"2017","unstructured":"Issa SF, Duer A, \u00d8stergaard M et al (2017) Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets. Arthritis Res Ther 19:80. https:\/\/doi.org\/10.1186\/s13075-017-1282-4","journal-title":"Arthritis Res Ther"},{"key":"6685_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/sji.12619","volume":"86","author":"SF Issa","year":"2017","unstructured":"Issa SF, Christensen AF, Lindegaard HM et al (2017) Galectin-3 is persistently increased in early rheumatoid arthritis (RA) and associates with anti-CCP seropositivity and MRI bone lesions, while early fibrosis markers correlate with disease activity. Scand J Immunol 86:471\u2013478. https:\/\/doi.org\/10.1111\/sji.12619","journal-title":"Scand J Immunol"},{"key":"6685_CR12","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/art.11287","volume":"48","author":"S Ohshima","year":"2003","unstructured":"Ohshima S, Kuchen S, Seemayer CA et al (2003) Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 48:2788\u20132795. https:\/\/doi.org\/10.1002\/art.11287","journal-title":"Arthritis Rheum"},{"key":"6685_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbspin.2016.02.029","volume":"84","author":"Y Hu","year":"2017","unstructured":"Hu Y, Y\u00e9l\u00e9h\u00e9-Okouma M, Ea H-K et al (2017) Galectin-3: a key player in arthritis. Joint Bone Spine 84:15\u201320. https:\/\/doi.org\/10.1016\/j.jbspin.2016.02.029","journal-title":"Joint Bone Spine"},{"key":"6685_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1756-185X.2011.01632.x","volume":"14","author":"MHM Ezzat","year":"2011","unstructured":"Ezzat MHM, El-Gammasy TMA, Shaheen KYA, Osman AOY (2011) Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression. Int J Rheum Dis 14:345\u2013352. https:\/\/doi.org\/10.1111\/j.1756-185X.2011.01632.x","journal-title":"Int J Rheum Dis"},{"key":"6685_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/clc.23105","volume":"42","author":"P Anyfanti","year":"2019","unstructured":"Anyfanti P, Gkaliagkousi E, Gavriilaki E et al (2019) Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis. Clin Cardiol 42:62\u201368. https:\/\/doi.org\/10.1002\/clc.23105","journal-title":"Clin Cardiol"},{"key":"6685_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/eurheartj\/eht151","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH\/ESC Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281\u20131357. https:\/\/doi.org\/10.1093\/eurheartj\/eht151","journal-title":"J Hypertens"},{"key":"6685_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0002-9149(78)90174-1","volume":"41","author":"J Hoffman","year":"1978","unstructured":"Hoffman J, Buckberg G (1978) The myocardial supply\u202f: demand ratio-a critical review. Am J Cardiol 41:327\u2013332","journal-title":"Am J Cardiol"},{"key":"6685_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/ajh\/hpz039","volume":"32","author":"P Anyfanti","year":"2019","unstructured":"Anyfanti P, Gkaliagkousi E, Triantafyllou A et al (2019) Noninvasive assessment of myocardial perfusion in different blood pressure phenotypes and its association with arterial stiffness indices. Am J Hypertens 32:557\u2013563. https:\/\/doi.org\/10.1093\/ajh\/hpz039","journal-title":"Am J Hypertens"},{"key":"6685_CR19","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","volume":"27","author":"S Laurent","year":"2006","unstructured":"Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588\u20132605. https:\/\/doi.org\/10.1093\/eurheartj\/ehl254","journal-title":"Eur Heart J"},{"key":"6685_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/14017431.2018.1453943","volume":"52","author":"P Anyfanti","year":"2018","unstructured":"Anyfanti P, Triantafyllou A, Gkaliagkousi E et al (2018) Association of non-invasive hemodynamics with arterial stiffness in rheumatoid arthritis. Scandinavian Cardiovasc J 52:171\u2013176. https:\/\/doi.org\/10.1080\/14017431.2018.1453943","journal-title":"Scandinavian Cardiovasc J"},{"key":"6685_CR21","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ajh\/hpu074","volume":"27","author":"A Triantafyllou","year":"2014","unstructured":"Triantafyllou A, Anyfanti P, Gavriilaki E et al (2014) Association between retinal vessel caliber and arterial stiffness in a population comprised of normotensive to early-stage hypertensive individuals. Am J Hypertens 27:1472\u20131478. https:\/\/doi.org\/10.1093\/ajh\/hpu074","journal-title":"Am J Hypertens"},{"key":"6685_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","volume":"33","author":"L Calvier","year":"2013","unstructured":"Calvier L, Miana M, Reboul P et al (2013) Galectin-3 mediates aldosterone-induced Vascular fibrosis. Arterioscler Thromb Vasc Biol 33:67\u201375. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300569","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6685_CR23","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel TJ et al (2004) Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110:3121\u20133128. https:\/\/doi.org\/10.1161\/01.CIR.0000147181.65298.4D","journal-title":"Circulation"},{"key":"6685_CR24","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1128\/MCB.00064-16","volume":"36","author":"M Bambouskova","year":"2016","unstructured":"Bambouskova M, Polakovicova I, Halova I et al (2016) New regulatory roles of galectin-3 in high-affinity IgE receptor signaling. Mol Cell Biol 36:1366\u20131382. https:\/\/doi.org\/10.1128\/MCB.00064-16","journal-title":"Mol Cell Biol"},{"key":"6685_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejr.2022.04.003","volume":"44","author":"NM Abdel Baki","year":"2022","unstructured":"Abdel Baki NM, Elgengehy FT, Zahran AM et al (2022) Galectin-3 and interleukin-7 as potential serologic markers in rheumatoid arthritis patients. Egyptian Rheumatologist 44:319\u2013324. https:\/\/doi.org\/10.1016\/j.ejr.2022.04.003","journal-title":"Egyptian Rheumatologist"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06685-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:09:33Z","timestamp":1699884573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06685-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6685"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06685-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}